These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 7503188)

  • 41. Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma.
    Kim JW; Cho YH; Kwon DJ; Kim TE; Park TC; Lee JM; Namkoong SE
    Gynecol Oncol; 1995 May; 57(2):199-204. PubMed ID: 7729734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of p53 gene mutations in a Brazilian population with oral squamous cell carcinomas.
    Chaves AC; Cherubini K; Herter N; Furian R; Santos DS; Squier C; Domann FE
    Int J Oncol; 2004 Feb; 24(2):295-303. PubMed ID: 14719105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of p53 point mutations in primary human vulvar cancer by PCR and temperature gradient gel electrophoresis.
    Sliutz G; Schmidt W; Tempfer C; Speiser P; Gitsch G; Eder S; Schneeberger C; Kainz C; Zeillinger R
    Gynecol Oncol; 1997 Jan; 64(1):93-8. PubMed ID: 8995554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The spectrum of TP53 mutations in bladder carcinoma.
    Williamson MP; Elder PA; Knowles MA
    Genes Chromosomes Cancer; 1994 Feb; 9(2):108-18. PubMed ID: 7513540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p53 mutations in larynx cancer.
    Zhang LF; Hemminki K; Szyfter K; Szyfter W; Söderkvist P
    Carcinogenesis; 1994 Dec; 15(12):2949-51. PubMed ID: 8001261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?
    Gallo O; Sardi I; Pepe G; Franchi A; Attanasio M; Giusti B; Bocciolini C; Abbate R
    Int J Cancer; 1999 Jul; 82(2):180-6. PubMed ID: 10389749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
    Yin CM; Yao YF; Yan ZL; Yang HY
    Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
    [No Abstract]   [Full Text] [Related]  

  • 48. C-deletion mutation of the p53 gene at exon 4 of codon 63 in the saliva of oral squamous cell carcinoma in central India: a preliminary study.
    Mewara A; Gadbail AR; Patil S; Chaudhary M; Chavhan SD
    J Investig Clin Dent; 2010 Nov; 1(2):108-13. PubMed ID: 25427266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p53 mutations in sporadic adrenocortical tumors.
    Ohgaki H; Kleihues P; Heitz PU
    Int J Cancer; 1993 May; 54(3):408-10. PubMed ID: 8509216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor suppressor p53 gene mutation in squamous cell carcinoma of the larynx.
    Sarkar FH; Sakr WA; Li YW; Jacobs J; Crissman JD
    Diagn Mol Pathol; 1996 Sep; 5(3):201-5. PubMed ID: 8866234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p53 mutations and overexpression in locally advanced breast cancers.
    Faille A; De Cremoux P; Extra JM; Linares G; Espie M; Bourstyn E; De Rocquancourt A; Giacchetti S; Marty M; Calvo F
    Br J Cancer; 1994 Jun; 69(6):1145-50. PubMed ID: 8198984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain.
    Challen C; Lunec J; Warren W; Collier J; Bassendine MF
    Hepatology; 1992 Dec; 16(6):1362-6. PubMed ID: 1332921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Detection of mutation in exon 5 and exon 8 of PTEN in laryngeal squamous cell carcinoma].
    Bai WL; Gao H; Ren Z; Pan ZM
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):13-6. PubMed ID: 15127561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. G --> A mutation of ras genes and infrequent p53 gene mutation in rat transplantable thyroid carcinoma lines from tumors induced in vivo by N-bis(2-hydroxypropyl)nitrosamine.
    Kitahori Y; Naitoh H; Konishi N; Fukushima M; Ohnishi T; Hiasa Y
    Cancer Lett; 1996 Feb; 100(1-2):55-62. PubMed ID: 8620454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiation response of vulvar squamous cell carcinoma (UM-SCV-1A, UM-SCV-1B, UM-SCV-2, and A-431) cells in vitro.
    Pekkola-Heino K; Kulmala J; Grenman S; Carey TE; Grenman R
    Cancer Res; 1989 Sep; 49(17):4876-8. PubMed ID: 2758419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The state of the p53 gene in human papillomavirus (HPV)-positive and HPV-negative genital precancer lesions and carcinomas as determined by single-strand conformation polymorphism analysis and sequencing.
    Kurvinen K; Tervahauta A; Syrjänen S; Chang F; Syrjänen K
    Anticancer Res; 1994; 14(1A):177-81. PubMed ID: 8166446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.
    Sameshima Y; Tsunematsu Y; Watanabe S; Tsukamoto T; Kawa-ha K; Hirata Y; Mizoguchi H; Sugimura T; Terada M; Yokota J
    J Natl Cancer Inst; 1992 May; 84(9):703-7. PubMed ID: 1569604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.